[1] 程文炜,闫晓芳,史静琤,等.基于GIS的中国中老年人糖尿病空间分布及其影响因素分析[J].中华疾病控制杂志,2017,21(9):1082-1087. [2] Hinnen D, Strong J. iGlarLixi:A new once-daily fixed-ratio combination of basal insulin glargine and lixisenatide for the management of type 2 diabetes[J]. Diabetes Spectr, 2018, 31(2):145-154. [3] Majedah M, Abdul R, Mohammad M, et al. A comparison of continuous subcutaneous insulin infusion vs multiple daily insulin injection in children with type Ⅰ diabetes in kuwait:glycemic control, insulin requirement, and BMI[J]. Oman Med J, 2015, 30(5):336-343. [4] Al Hayek AA, Robert AA, Al Dawish, et al. Efficacy of insulin pump therapy on diabetes treatment satisfaction and glycemic control among patients with type 1 diabetes mellitus in saudi arabia:A prospective study[J]. Diabetes Ther, 2015, 6(2):227-236. [5] 凌丽.不同方案胰岛素强化治疗2型糖尿病的临床效果观察[J].中国医学前沿杂志:电子版,2015,7(9):36-39. [6] Ziegler R, Freckmann G, Heinemann L. Boluses in insulin therapy[J]. J Diabetes Sci Technol, 2017, 11(1):165-171. [7] 荣义华,谷巍,耿建林,等.不同胰岛素皮下注射方案T2DM患者的血糖变异性比较[J]. 中国现代医学杂志,2017,27(17):103-107. [8] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版)[J]. 中国实用内科杂志,2018,38(4):292-344. [9] American Diabetes Association.Standards of medical care in diabetes-2017[J]. Diabetes Care, 2017, 40(Suppl1):S1-135. [10] American Diabetes Association. Standards of medical care in diabetes-2016[J]. Diabetes Care, 2016, 39(Suppl1):S1-112. [11] Neuhāuser M, Bretz F. Nonparametric all-Pairs mutiple comparisons[J]. Biom J,2015, 43(5):571-580. [12] 刘春英,刘彩霞.采用胰岛素泵治疗2型糖尿病的疗效及对患者生活质量的影响[J].中国基层医药,2015,22(3):419-421. [13] Piri S, Delen D, Liu TM, et al. Development of a new metric to identify rare patterns in association analysis:the case of analyzing diabetes complications[J]. Expert Syst Appl, 2018, 94(3):112-125. [14] King A, Philis-Tsimikas A, Kilpatrick E. A fixed ratio combination of insulin degludec and liraglutide (IDegLira) reduces glycemic fluctuation and brings more patients with type 2 diabetes within blood glucose target ranges[J]. Diabetes Technol Ther, 2017, 4(19):255-264. [15] McEwan P, Thorsted BL, Wolden M, et al.Healthcare resource implications of hypogly-cemia-related hospital admissions and inpatient hypoglycemia:retrospective record-linked cohort studies in England[J]. BMJ Open Diabetes Res Care, 2015, 3(1):e000057. [16] Kakuta K, Dohi K, Miyoshi M, et al. Impact of renal function on the underlying pathophysiology of coronary plaque composition in patients with type 2 diabetes mellitus[J]. Cardiovasc Diabetol, 2017, 16(1):131. [17] Johansen N, Christensen M. A systematic review on insulin overdose cases:clinical course, complications and treatment options[J]. Basic Clin Pharmacol Toxicol, 2018, 6(122):650-659. [18] Giannoulaki P, Gounitsioti I, Iliadis F. Bolus wizard use has a beneficial effect in glycemic control among people with diabetes type 1 on insulin pump therapy[J].Clin Nutrit Espen, 2016, 6(13):e62-e63. [19] Ziegler R, Rees C, Jacobs N, et al. Frequent use of an automated bolus advisor improves glycemic control in pediatric patients treated with insulin pump therapy:results of the Bolus Advisor Benefit Evaluation (BABE) study[J]. Pediatr Diabetes, 2016,17(5):311-318. [20] Gu W, Liu Y, Chen Y, et al. Multicentre randomized controlled trial with sensor-augmented pump vs multiple daily injections in hospitalized patients with type 2 diabetes in China:Time to reach target glucose[J]. Diabetes Metab, 2017, 43(4):359-363. [21] 孙正凯,魏进,韩玉亭.动态血糖监测系统对2型糖尿病患者强化治疗中血糖波动监测的价值[J].山东医药,2016,56(37):69-71. [22] Ziegler R, Rees C, Jacobs N, et al. Frequent use of an automated bolus advisor improves glycemic control in pediatric patients treated with insulin pump therapy:results of the Bolus Advisor Benefit Evaluation (BABE) study[J]. Pediatr Diabetes, 2016, 17(5):311-318. |